FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2991126115> ?p ?o ?g. }

• W2991126115 abstract "Abstract Background The combination of gemcitabine and nab-paclitaxel (GnP) has been established as the first-line chemotherapy in patients (pts) with metastatic pancreatic cancer (M-PC). However, the efficacy of the therapy in pts with borderline resectable PC (BR-PC) and locally advanced PC (LA-PC) is not clear. Although achieving R0 resection is one of the main target for these pts, the details of the response, such as the best time to evaluate the response is not clear. Therefore, we evaluated the details of response with GnP treatment. Methods We retrospectively reviewed the medical records of pts with BR-PC, LA-PC, and M-PC who received GnP as the first-line chemotherapy between January 2016 and April 2019 at six hospitals. We investigated time to response (TTR), duration of response (DoR), and depth of response (DpR). The response of the primary tumor and the metastases were evaluated separately in pts with M-PC. The response of the primary tumor was evaluated in all pts. Results A total of 47 pts were analyzed; the median age was 70 years, male was 66% and the number of pts with BR-PC/LA-PC/M-PC was 6%/26%/68%. The response rates of primary tumor and metastases were 40% and 31%, respectively. Among the pts with M-PC, seven had a partial response (PR) of the primary tumor without PR of metastases. The median TTR and time to best response of the primary tumor and metastases were 3.17 months (m) and 4.21 m (p = 0.191), and 4.11 m and 5.88 m (p = 0.724), respectively. The median DoR of the primary tumor and metastases were 5.36 m and 4.11 m, respectively (p = 0.277). The median DpR of the primary tumor and metastases were 28.3% and 15.3%, respectively (p = 0.733). The median progression-free survival and overall survival in M-PC pts with and without PR of the primary tumor were 8.48 m and 6.41 m (p = 0.267), and 14.72 m and 7.66 m (p = 0.186), respectively. Conclusions The response of the primary tumor tended to be higher and earlier than that of the metastases. A favorable efficacy was observed in pts with BR-PC and LA-PC as well as pts with M-PC. This study indicated that the best time to evaluate the response of the primary site to consider the conversion therapy was around 4 m. Pts with M-PC showing PR of the primary tumor tended to have a favorable prognosis. Legal entity responsible for the study The authors. Funding Has not received any funding. Disclosure All authors have declared no conflicts of interest." @default.
• W2991126115 created "2019-12-05" @default.
• W2991126115 creator A5000250722 @default.
• W2991126115 creator A5005964437 @default.
• W2991126115 creator A5010897098 @default.
• W2991126115 creator A5029733589 @default.
• W2991126115 creator A5037542675 @default.
• W2991126115 creator A5040079505 @default.
• W2991126115 creator A5045059146 @default.
• W2991126115 creator A5048908270 @default.
• W2991126115 creator A5054899877 @default.
• W2991126115 creator A5066413780 @default.
• W2991126115 creator A5070899217 @default.
• W2991126115 creator A5077827101 @default.
• W2991126115 creator A5083128998 @default.
• W2991126115 date "2019-11-01" @default.
• W2991126115 modified "2023-09-28" @default.
• W2991126115 title "Details of response with first-line gemcitabine and nab-paclitaxel therapy in patients with advanced pancreatic cancer" @default.
• W2991126115 doi "https://doi.org/10.1093/annonc/mdz422.067" @default.
• W2991126115 hasPublicationYear "2019" @default.
• W2991126115 type Work @default.
• W2991126115 sameAs 2991126115 @default.
• W2991126115 citedByCount "0" @default.
• W2991126115 crossrefType "journal-article" @default.
• W2991126115 hasAuthorship W2991126115A5000250722 @default.
• W2991126115 hasAuthorship W2991126115A5005964437 @default.
• W2991126115 hasAuthorship W2991126115A5010897098 @default.
• W2991126115 hasAuthorship W2991126115A5029733589 @default.
• W2991126115 hasAuthorship W2991126115A5037542675 @default.
• W2991126115 hasAuthorship W2991126115A5040079505 @default.
• W2991126115 hasAuthorship W2991126115A5045059146 @default.
• W2991126115 hasAuthorship W2991126115A5048908270 @default.
• W2991126115 hasAuthorship W2991126115A5054899877 @default.
• W2991126115 hasAuthorship W2991126115A5066413780 @default.
• W2991126115 hasAuthorship W2991126115A5070899217 @default.
• W2991126115 hasAuthorship W2991126115A5077827101 @default.
• W2991126115 hasAuthorship W2991126115A5083128998 @default.
• W2991126115 hasBestOaLocation W29911261151 @default.
• W2991126115 hasConcept C121608353 @default.
• W2991126115 hasConcept C126322002 @default.
• W2991126115 hasConcept C141071460 @default.
• W2991126115 hasConcept C143998085 @default.
• W2991126115 hasConcept C2776694085 @default.
• W2991126115 hasConcept C2777292972 @default.
• W2991126115 hasConcept C2778822529 @default.
• W2991126115 hasConcept C2779013556 @default.
• W2991126115 hasConcept C2779984678 @default.
• W2991126115 hasConcept C2780210213 @default.
• W2991126115 hasConcept C2780258809 @default.
• W2991126115 hasConcept C2780283643 @default.
• W2991126115 hasConcept C3019096185 @default.
• W2991126115 hasConcept C71924100 @default.
• W2991126115 hasConcept C90924648 @default.
• W2991126115 hasConceptScore W2991126115C121608353 @default.
• W2991126115 hasConceptScore W2991126115C126322002 @default.
• W2991126115 hasConceptScore W2991126115C141071460 @default.
• W2991126115 hasConceptScore W2991126115C143998085 @default.
• W2991126115 hasConceptScore W2991126115C2776694085 @default.
• W2991126115 hasConceptScore W2991126115C2777292972 @default.
• W2991126115 hasConceptScore W2991126115C2778822529 @default.
• W2991126115 hasConceptScore W2991126115C2779013556 @default.
• W2991126115 hasConceptScore W2991126115C2779984678 @default.
• W2991126115 hasConceptScore W2991126115C2780210213 @default.
• W2991126115 hasConceptScore W2991126115C2780258809 @default.
• W2991126115 hasConceptScore W2991126115C2780283643 @default.
• W2991126115 hasConceptScore W2991126115C3019096185 @default.
• W2991126115 hasConceptScore W2991126115C71924100 @default.
• W2991126115 hasConceptScore W2991126115C90924648 @default.
• W2991126115 hasLocation W29911261151 @default.
• W2991126115 hasOpenAccess W2991126115 @default.
• W2991126115 hasPrimaryLocation W29911261151 @default.
• W2991126115 isParatext "false" @default.
• W2991126115 isRetracted "false" @default.
• W2991126115 magId "2991126115" @default.
• W2991126115 workType "article" @default.